Section Arrow
Quote
AVDL.NASDAQ
- Avadel Pharmaceuticals plc
Quotes are at least 15-min delayed:2025/07/04 11:21 EDT
Last
 8.93
+0.12 (+1.36%)
Day High 
8.945 
Prev. Close
8.81 
1-M High
10.5 
Volume 
361.57K 
Bid
8.7
Ask
9.8
Day Low
8.78 
Open
8.89 
1-M Low
8.5194 
Market Cap 
853.69M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.2 
20-SMA 9.42 
50-SMA 9.16 
52-W High 17.298 
52-W Low 6.38 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.26/1.59
Enterprise Value
854.82M
Balance Sheet
Book Value Per Share
0.76
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
169.12M
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/04 11:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.